McNicoll Lewis & Vlak Starts Bacterin International (BONE) at Buy; A BONE-a-fide Growth Story
Get Alerts BONE Hot Sheet
Price: $3.25 --0%
Rating Summary:
3 Buy, 0 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
3 Buy, 0 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
McNicoll Lewis & Vlak initiates coverage on Bacterin International (NYSE: BONE) with a Buy. PT $5.00.
MLV analyst says, "We think that Bacterin International has a broad and expanding product portfolio and is poised for growth. The OsteoSponge bone void filler has compelling data that we think could allow the Company to take market share from Medtronic’s (NYSE: MDT)(Not Covered) INFUSE product, as well other products."
For more ratings news on Bacterin International click here and for the rating history of Bacterin International click here.
Shares of Bacterin International closed at $1.76 yesterday.
MLV analyst says, "We think that Bacterin International has a broad and expanding product portfolio and is poised for growth. The OsteoSponge bone void filler has compelling data that we think could allow the Company to take market share from Medtronic’s (NYSE: MDT)(Not Covered) INFUSE product, as well other products."
For more ratings news on Bacterin International click here and for the rating history of Bacterin International click here.
Shares of Bacterin International closed at $1.76 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- Medtronic (MDT) Declares $0.72 Quarterly Dividend; 3.1% Yield
- H.C. Wainwright Starts ImageneBio (IMA) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share